APA

Mulvihill E. E., Assini J. M., Sutherland B. G., DiMattia A. S., Khami M., Koppes J. B., Sawyez C. G., Whitman S. C. & Huff M. W. (20100416). Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. : Arteriosclerosis, thrombosis, and vascular biology.

Chicago

Mulvihill Erin E, Assini Julia M, Sutherland Brian G, DiMattia Alessandra S, Khami Maryam, Koppes Julie B, Sawyez Cynthia G, Whitman Stewart C and Huff Murray W. 20100416. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. : Arteriosclerosis, thrombosis, and vascular biology.

Harvard

Mulvihill E. E., Assini J. M., Sutherland B. G., DiMattia A. S., Khami M., Koppes J. B., Sawyez C. G., Whitman S. C. and Huff M. W. (20100416). Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. : Arteriosclerosis, thrombosis, and vascular biology.

MLA

Mulvihill Erin E, Assini Julia M, Sutherland Brian G, DiMattia Alessandra S, Khami Maryam, Koppes Julie B, Sawyez Cynthia G, Whitman Stewart C and Huff Murray W. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. : Arteriosclerosis, thrombosis, and vascular biology. 20100416.